JPH0160468B2 - - Google Patents
Info
- Publication number
- JPH0160468B2 JPH0160468B2 JP24819184A JP24819184A JPH0160468B2 JP H0160468 B2 JPH0160468 B2 JP H0160468B2 JP 24819184 A JP24819184 A JP 24819184A JP 24819184 A JP24819184 A JP 24819184A JP H0160468 B2 JPH0160468 B2 JP H0160468B2
- Authority
- JP
- Japan
- Prior art keywords
- cotinine
- oxide
- amount
- solvent
- aminocotinine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 33
- UIKROCXWUNQSPJ-VIFPVBQESA-N (-)-cotinine Chemical compound C1CC(=O)N(C)[C@@H]1C1=CC=CN=C1 UIKROCXWUNQSPJ-VIFPVBQESA-N 0.000 claims description 16
- UIKROCXWUNQSPJ-UHFFFAOYSA-N Cotinine Natural products C1CC(=O)N(C)C1C1=CC=CN=C1 UIKROCXWUNQSPJ-UHFFFAOYSA-N 0.000 claims description 13
- 229950006073 cotinine Drugs 0.000 claims description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 5
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 4
- CIPULDKLIIVIER-VIFPVBQESA-N cotinine N-oxide Chemical compound C1CC(=O)N(C)[C@@H]1C1=CC=CN(=O)=C1 CIPULDKLIIVIER-VIFPVBQESA-N 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 150000004965 peroxy acids Chemical class 0.000 claims description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- 239000000427 antigen Substances 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 235000002597 Solanum melongena Nutrition 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical group CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical group O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は新規かつ有用な4―アミノコチニン及
び、その製造方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a novel and useful 4-aminocotinine and a method for producing the same.
(従来の技術)
近年、人工抗原の研究は人体あるいは薬物によ
る治療など医学的、及び生物学的研究分野におい
て盛んに行なわれており、たとえば、インシユリ
ン、モルフイン、LSDなどの人工抗原が実際に
合成され、これらが研究の進展に大きく寄与して
いることは周知のことである。ニコチンやその代
謝産物であるコチニンについても喫煙医学的見地
から、これが人体に及ぼす影響について長年にわ
たり研究が続けられており、これらの人工抗原も
合成され、これが微量コチニンの放射免疫定量へ
の応用についても実際に行なわれている。(Prior Art) In recent years, research on artificial antigens has been actively conducted in the medical and biological research fields, such as treatment with the human body or drugs. It is well known that these methods greatly contribute to the progress of research. Research has continued for many years on the effects of nicotine and its metabolite cotinine on the human body from the medical perspective of smoking, and these artificial antigens have also been synthesized, leading to their application to radioimmunoquantification of trace amounts of cotinine. is actually being carried out.
(発明が解決しようとする問題点)
しかし、天然の葉たばこ中に存在するニコチン
の代謝産物であるコチニンはすべて1体で存在し
ているので、通常必要とされる人工抗原の抗体は
1体のみに特異的に反応するものが望ましいが、
従来の人工抗原の合成方法の多くは、その合成過
程においてラセミ化を起こしてしまう。そのた
め、通常必要とされる人工抗原の1体抗体産出能
力を半減してしまう欠点があつた。この欠点を改
善し本化合物に類似した光学活性なコチニン誘導
体が提案されている(特公、昭54−914)。しか
し、このコチニン誘導体は、単離精製が煩雑であ
り、また極めて吸湿性の高い化合物であるため、
保管や取り扱いが不便である。(Problem to be solved by the invention) However, since cotinine, which is a metabolite of nicotine that exists in natural leaf tobacco, exists as a single body, only one body of the artificial antigen antibody is normally required. It is desirable to have something that specifically reacts to
Many of the conventional methods for synthesizing artificial antigens cause racemization during the synthesis process. Therefore, the drawback was that the normally required ability of artificial antigens to produce one-body antibodies was halved. An optically active cotinine derivative similar to the present compound has been proposed to improve this drawback (Japanese Patent Publication, 1982-914). However, this cotinine derivative is complicated to isolate and purify, and is an extremely hygroscopic compound.
Storage and handling are inconvenient.
本発明は、このような従来の公知のコチニン誘
導体に伴なう欠点がなく、合成方法及び単離方法
が極めて容易で、かつ、光学純度を保つたまま製
造しうるコチニン誘導体を提供することを目的と
したものである。 The object of the present invention is to provide a cotinine derivative that does not have the drawbacks associated with conventionally known cotinine derivatives, can be produced by extremely easy synthesis and isolation methods, and can be produced while maintaining optical purity. This is the purpose.
(問題点を解決するための手段)
すなわち、本発明は次式に示す4―アミノコチ
ニン及び、その製造方法である。(Means for solving the problems) That is, the present invention is 4-aminocotinine shown by the following formula and a method for producing the same.
本化合物は、文献未載の新規化合物であり、以
下にその物性値を示す。 This compound is a new compound that has not been published in any literature, and its physical properties are shown below.
4―アミノコチニン
性状;白色結晶
融点;195〜196℃
IR(cm-1);1377,1453,1462,1600,1666,
16801
H NMR(溶媒CDCL3、内部標準TMS);
(ppm)
2.15(m,1H),2.38(m,1H),2.51(m,
1H),2.56(m,1H),2.74(s,3H),4.55
(bs,2H),4.56(t,J=8.1Hz,1H),6.56
(d,J=5.4Hz,1H),8.06(s,1H),8.17
(d,J=5.4Hz,1H)13
C NMR(溶媒CDCL3,内部標準TMS);
(ppm)
24.21(t),28.31(q),30.43(t),61.00
(d),110.79(d),117.51(s),149.22(s),
149.89(d),151.00(d),175.75(s)
MASS;(m/Z)
191(M+:100),98(41),119(53),120
(25),133(39),134(45),148(33),162
(71),163(34),176(21)
施光度;〔α〕25 d=−117.9゜(c=2.2,MeOH)
4―アミノコチニンは、コチニンを過酸で酸化
してコチニン―N―オキシドとした後、濃硫酸、
発煙硝酸でニトロ化し、酢酸中、鉄で還元するこ
とにより容易に得ることができる。以下に、その
製造方法を後述の製造例にもとづいて詳細に説明
する。 4-Aminocotinine Properties: White crystal Melting point: 195-196℃ IR (cm -1 ): 1377, 1453, 1462, 1600, 1666,
1680 1 H NMR (solvent CDCL 3 , internal standard TMS);
(ppm) 2.15 (m, 1H), 2.38 (m, 1H), 2.51 (m,
1H), 2.56 (m, 1H), 2.74 (s, 3H), 4.55
(bs, 2H), 4.56 (t, J=8.1Hz, 1H), 6.56
(d, J=5.4Hz, 1H), 8.06 (s, 1H), 8.17
(d, J = 5.4Hz, 1H) 13 C NMR (solvent CDCL 3 , internal standard TMS);
(ppm) 24.21 (t), 28.31 (q), 30.43 (t), 61.00
(d), 110.79(d), 117.51(s), 149.22(s),
149.89 (d), 151.00 (d), 175.75 (s) MASS; (m/Z) 191 (M+: 100), 98 (41), 119 (53), 120
(25), 133 (39), 134 (45), 148 (33), 162
(71), 163 (34), 176 (21) Light exposure; [α] 25 d = -117.9° (c = 2.2, MeOH) 4-Aminocotinine is produced by oxidizing cotinine with peracid to form cotinine-N- After converting into oxide, concentrated sulfuric acid,
It can be easily obtained by nitration with fuming nitric acid and reduction with iron in acetic acid. The manufacturing method will be described in detail below based on manufacturing examples described later.
コチニンを、コチニンに対し2〜5倍量、望ま
しくは3倍量の酢酸に溶解させ、酢酸に対し0.2
倍量の30%過酸化水素水を加え、70℃で1〜10時
間、望ましくは5時間反応させる。反応後減圧下
溶媒を留去させ、エチルアルコール、メチルアル
コール等のアルコールを適当量加え、過剰の過酸
化水素を分解させ、水を加え減圧下溶媒を留去さ
せる。得られた油状物質に炭酸カリウム、炭酸ナ
トリウム等のアルカリを加え中和させ、クロロフ
オルム、ジクロロメタン等の有機溶媒で抽出し、
硫酸ナトリウム、硫酸マグネシウム等で乾燥さ
せ、減圧下溶媒を留去させると、コチニン―N―
オキシドが収率95〜99%で白色結晶として得られ
る。 Cotinine is dissolved in 2 to 5 times the amount of cotinine, preferably 3 times the amount of acetic acid, and 0.2 times the amount of cotinine is dissolved in acetic acid.
Add twice the amount of 30% hydrogen peroxide solution and react at 70°C for 1 to 10 hours, preferably 5 hours. After the reaction, the solvent is distilled off under reduced pressure, an appropriate amount of alcohol such as ethyl alcohol or methyl alcohol is added to decompose excess hydrogen peroxide, water is added, and the solvent is distilled off under reduced pressure. The obtained oily substance is neutralized by adding an alkali such as potassium carbonate or sodium carbonate, and extracted with an organic solvent such as chloroform or dichloromethane.
After drying with sodium sulfate, magnesium sulfate, etc. and distilling off the solvent under reduced pressure, cotinine-N-
The oxide is obtained as white crystals with a yield of 95-99%.
得られたコチニン―N―オキシドを、それに対
し10〜20倍量、望ましくは12倍量の濃硫酸及び同
量の発煙硝酸に溶解させ、130℃で3〜10時間、
望ましくは5時間反応させる。反応後、反応液
を、加えた濃硫酸の2倍量程度の氷に注意深く注
ぐ。次に、炭酸カリウム、炭酸ナトリウム等のア
ルカリを加え中和し、クロロフオルム、ジクロロ
メタン等の有機溶媒で抽出する。抽出液を硫酸ナ
トリウム、硫酸マグネシウム等で乾燥させた後、
減圧下溶媒を留去し、少量のクロロフオルムで再
結晶させると、4―ニトロコチニン―N―オキシ
ドが収率30〜45%で薄黄色の結晶として得られ
る。 The obtained cotinine-N-oxide was dissolved in 10 to 20 times its amount, preferably 12 times its amount, of concentrated sulfuric acid and the same amount of fuming nitric acid, and then heated at 130°C for 3 to 10 hours.
Preferably, the reaction is allowed to proceed for 5 hours. After the reaction, carefully pour the reaction solution onto ice with an amount twice as much as the amount of concentrated sulfuric acid added. Next, an alkali such as potassium carbonate or sodium carbonate is added to neutralize the mixture, and the mixture is extracted with an organic solvent such as chloroform or dichloromethane. After drying the extract with sodium sulfate, magnesium sulfate, etc.
The solvent is distilled off under reduced pressure and recrystallized from a small amount of chloroform to obtain 4-nitrocotinine-N-oxide as pale yellow crystals in a yield of 30-45%.
得られた4―ニトロコチニン―N―オキシド
を、それに対し5〜20倍量、望ましくは8倍量の
酢酸に溶解させ、4―ニトロコチニン―N―オキ
シドに対し1〜3倍量、望ましくは2倍量の鉄粉
を加え、2〜10時間、望ましくは3時間酢酸の沸
点で還流させる。反応後、未反応の鉄粉をろ過
し、減圧下酢酸を留去した後、炭酸カリウム、炭
酸ナトリウム等のアルカリで中和し、クロロフオ
ルム、ジクロロメタン等の有機溶媒で抽出し、硫
酸ナトリウム、硫酸マグネシウム等で乾燥させ、
減圧下溶媒を留去させた後、少量のクロロフオル
ムで再結晶させると、4―アミノコチニンが収率
40〜65%で白色結晶として得られる。 The obtained 4-nitrocotinine-N-oxide is dissolved in 5 to 20 times the amount of acetic acid, preferably 8 times the amount of 4-nitrocotinine-N-oxide. Add twice the amount of iron powder and reflux at the boiling point of acetic acid for 2 to 10 hours, preferably 3 hours. After the reaction, unreacted iron powder is filtered, acetic acid is distilled off under reduced pressure, neutralized with an alkali such as potassium carbonate or sodium carbonate, extracted with an organic solvent such as chloroform or dichloromethane, and extracted with sodium sulfate or magnesium sulfate. Dry with etc.
After distilling off the solvent under reduced pressure, recrystallization from a small amount of chloroform yields 4-aminocotinine.
Obtained as white crystals at 40-65%.
以上詳細に説明したように、本発明による製造
方法は、アミノ基が位置選択的に4位に導入で
き、さらに光学純度を失なうことなく製造するこ
とができることから、後で述べるように、コチニ
ンの人工抗原として極めて重要な特徴である、ピ
リジン環、ピロリドン環、さらに光学活性を維持
しているという利点がある、以下にその製造例を
示す。 As explained in detail above, the production method according to the present invention allows the amino group to be introduced into the 4-position regioselectively, and can be produced without losing optical purity. An example of its production is shown below, which has the advantage of maintaining the pyridine ring and pyrrolidone ring, which are extremely important features as an artificial antigen of cotinine, as well as optical activity.
(実施例)
100mlナスフラスコ中、3.4g(20mmol)のコ
チニンを、12mlの酢酸に溶解させ、その溶液中に
30%過酸化水素2.4mlを加えて70℃で5時間反応
させる。反応後、減圧下酢酸を留去しエチルアル
コールを加え過剰の過酸化水素を処理し、水を加
え減圧下溶媒を留去し、炭酸カリウムで中和し、
クロロフオルムで抽出し硫酸ナトリウムで乾燥さ
せ溶媒を留去し、コチニン―N―オキシドを白色
結晶として3.7g(収率98%)得た。(Example) In a 100 ml eggplant flask, 3.4 g (20 mmol) of cotinine was dissolved in 12 ml of acetic acid.
Add 2.4 ml of 30% hydrogen peroxide and react at 70°C for 5 hours. After the reaction, acetic acid was distilled off under reduced pressure, ethyl alcohol was added to remove excess hydrogen peroxide, water was added, the solvent was distilled off under reduced pressure, and the mixture was neutralized with potassium carbonate.
The extract was extracted with chloroform, dried over sodium sulfate, and the solvent was distilled off to obtain 3.7 g (yield 98%) of cotinine-N-oxide as white crystals.
得られたコチニン―N―オキシド3.7g
(19mmol)を100mlナスフラスコ中、濃硫酸40
ml、発煙硝酸40mlに溶解させ130℃で5時間反応
させる。反応後、反応液を100mlの氷に注ぎ炭酸
カリウムで中和し、クロロフオルムで抽出し硫酸
ナトリウムで乾燥させ溶媒を留去した後、少量の
クロロフオルムで再結晶させ、4―ニトロコチニ
ン―N―オキシドを薄黄色の針状結晶として1.8
g(収率40%)得た。 3.7 g of cotinine-N-oxide obtained
(19 mmol) in a 100 ml eggplant flask, concentrated sulfuric acid 40
ml, dissolved in 40 ml of fuming nitric acid and reacted at 130°C for 5 hours. After the reaction, the reaction solution was poured into 100 ml of ice, neutralized with potassium carbonate, extracted with chloroform, dried over sodium sulfate, the solvent was distilled off, recrystallized with a small amount of chloroform, and 4-nitrocotinine-N-oxide was obtained. 1.8 as light yellow needle-shaped crystals
g (yield 40%) was obtained.
得られた4―ニトロコチニン―N―オキシド
1.8g(7.6mmol)を100mlナスフラスコ中、酢酸
20mlに溶解させ、鉄粉4gを加え3時間還流させ
る。反応後、未反応の鉄粉をろ過し、減圧下酢酸
を留去した後、炭酸カリウムで中和し、水酸化鉄
をろ別し、クロロフオルムで抽出し、硫酸ナトリ
ウムで乾燥させ、溶媒を減圧下留去した後、少量
のクロロフオルムで再結晶させ、4―アミノコチ
ニンを1.0g(収率56%)得た。 Obtained 4-nitrocotinine-N-oxide
1.8g (7.6mmol) of acetic acid in a 100ml eggplant flask
Dissolve in 20 ml, add 4 g of iron powder, and reflux for 3 hours. After the reaction, unreacted iron powder is filtered, acetic acid is distilled off under reduced pressure, neutralized with potassium carbonate, iron hydroxide is filtered off, extracted with chloroform, dried over sodium sulfate, and the solvent is removed under reduced pressure. After evaporation, the residue was recrystallized from a small amount of chloroform to obtain 1.0 g (yield: 56%) of 4-aminocotinine.
(発明の効果)
1―アミノコチニンは上述したように、カルボ
キシル基を有する蛋白質などの高分子化合物とペ
プチド合成試薬を用いて結合させることにより、
コチニンの人工抗原として利用することができ、
これらの人工抗原は高い抗体価の抗体を産出せし
める能力がある。すなわち、本発明の化合物の構
造式から明らかなように、これらの人工抗原は本
発明化合物の一級アミノ基において高分子化合物
と結合しているので、コチニンの構造、特にその
特徴であるピリジン環、N―メチルピロリドン環
になんらの変化を加えることなく、特異性の高い
抗体を産出せしめる一因となつている。(Effect of the invention) As mentioned above, 1-aminocotinine can be bonded to a polymeric compound such as a protein having a carboxyl group using a peptide synthesis reagent.
It can be used as an artificial antigen for cotinine,
These artificial antigens have the ability to produce antibodies with high titers. That is, as is clear from the structural formula of the compound of the present invention, these artificial antigens are bonded to a polymer compound at the primary amino group of the compound of the present invention. This contributes to the production of highly specific antibodies without making any changes to the N-methylpyrrolidone ring.
さらに、本発明化合物より得られた人工抗原が
動物体内に産出させる抗体はl―コチニンに対し
て特異的に反応し、d―コチニンとの交叉反応が
小さいなど従来知られているコチニンの人工抗原
に比し極めてすぐれた利点がある。 Furthermore, the antibodies produced in the animal body by the artificial antigen obtained from the compound of the present invention react specifically against l-cotinine, and have a small cross-reaction with d-cotinine, which is a previously known artificial antigen of cotinine. It has significant advantages over.
Claims (1)
シドとした後濃硫酸、発煙硝酸と反応させ、4―
ニトロコチニン―N―オキシドとし、酢酸中、鉄
で還元することを特徴とする4―アミノコチニン
の製造方法。[Claims] 4-aminocotinine represented by the linear formula 2 Cotinine is treated with peracid to form cotinine-N-oxide, and then reacted with concentrated sulfuric acid and fuming nitric acid to form 4-
A method for producing 4-aminocotinine, which comprises reducing the nitrocotinine-N-oxide with iron in acetic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24819184A JPS61126083A (en) | 1984-11-26 | 1984-11-26 | 4-aminocotinine and production thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24819184A JPS61126083A (en) | 1984-11-26 | 1984-11-26 | 4-aminocotinine and production thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61126083A JPS61126083A (en) | 1986-06-13 |
| JPH0160468B2 true JPH0160468B2 (en) | 1989-12-22 |
Family
ID=17174556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP24819184A Granted JPS61126083A (en) | 1984-11-26 | 1984-11-26 | 4-aminocotinine and production thereof |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61126083A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164504A (en) * | 1991-01-16 | 1992-11-17 | Abbott Laboratories | Haptens, tracers, immunogens and antibodies for immunoassays for cotinine derivatives |
-
1984
- 1984-11-26 JP JP24819184A patent/JPS61126083A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61126083A (en) | 1986-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1340549C (en) | Method of preparing sphingosine derivatives | |
| JPS6353987B2 (en) | ||
| JPH0529216B2 (en) | ||
| WO1995004062A1 (en) | Synthesis of 4,10-dinitro-2,6,8,12-tetraoxa-4,10-diazatetracyclo[5.5.0.0?5,903,11¿]dodecane | |
| JPH0160468B2 (en) | ||
| US5446166A (en) | Preparation of pyrrol and oxazole compounds: formation of porphyrins and C-acyl-α-amino acid esters therefrom | |
| JPH0160469B2 (en) | ||
| KR100625649B1 (en) | Method for preparing β-hydroxybutyl acid alkyl ester | |
| JP3303050B2 (en) | Azonia adamantane compound, method for producing azaadamantane compound therefrom and method for producing said azoniaadamantane compound | |
| JP3026238B2 (en) | Novel 4-methoxy-2- (2-tetrahydropyranyloxymethyl) pyridine compounds, intermediates for producing the same, and methods for producing them | |
| JPH026348B2 (en) | ||
| Chang et al. | Synthesis of (±)-rolipram | |
| KR100856133B1 (en) | Improved process for preparing atorvastatin | |
| CN109280049B (en) | Synthetic method of medical compound avanafil | |
| JPS59137465A (en) | Manufacture of imidazole-4,5-dicarboxylic acid | |
| JP2007262040A (en) | Method for producing 3-substituted aminocyclic amine derivative | |
| JPS5852995B2 (en) | Method for producing furfural derivatives | |
| JP2009096744A (en) | Mannich reaction using cyclic amino ether | |
| KR101009467B1 (en) | Taxane derivatives useful for the synthesis of docetaxel and preparation methods thereof | |
| JPS63211264A (en) | Production of indolines | |
| JPS6053021B2 (en) | Production method of hydantoin | |
| KR0140323B1 (en) | PROCESS FOR PREPARING OPTICAL ACTIVE Ñß-AMINOACID | |
| JP2012036161A (en) | Method for producing optically active trifluoromethylcyclopropane compound | |
| JPH0437077B2 (en) | ||
| FR2777278A1 (en) | Production of 3-hydroxymethyl-quinuclidine useful as intermediate for antihistamine mequitazine |